Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Tuberculosis Testing Market to Cross US$ 2600 Million by 2020

Market Research Engine
Posted on: 29 Sep 16
Tuberculosis Testing Market to Cross US$ 2600 Million by 2020

New York, September 29: Market Research Engine has published a new report titled as “Tuberculosis Testing Market by Test type (Smear Microscopy, Culture Based Tests, Nucleic Acid Testing, Mantoux Test, Radiography (Chest X-Ray), Drug Susceptibility Testing (DST) and Other TB Tests) - Global Industry Analysis, Trends and Forecast 2015 – 2021”

The Tuberculosis Testing market is expected to exceed more than US$ 2600 million by 2020; growing at a CAGR of more than 4.2% in the given forecast period.

Browse Full Report:

Tuberculosis tests are existing to diagnosis tuberculosis. These tests are used to discover tuberculosis bacteria which are subjected to tuberculosis drug resistant or TB drug treatment. Tuberculosis test are used to determine if someone has infected with tuberculosis bacteria. The expansion of tuberculosis disease is occurring in two stages. In first stage a person contains TB bacteria that are latent TB. In second stage the TB bacteria will reproduced adequately which cause the patient to have become unwell. Analysis of active tuberculosis will be confirmed when there is a distinct confirmation of TB bacteria in the human’s body. Chest X- ray is used when person contains TB bacteria when caused swelling in lungs. Increasing demand for technologically advanced, improved and new TB testing equipment and procedure is the main cause in rise of the TB testing demand.

The major driving factors of tuberculosis testing market are as follows:

•    Increasing tuberculosis awareness and control events from non government and government.
•    Increased approval of many tuberculosis testing techniques because of high incidence and   occurrence rates of the disease.
•    Rising demand for many tuberculosis tests.

The restraining factors of tuberculosis testing market are as follows:

•    Costs of many tuberculosis tests are very high.

Download Free Sample Report:

The tuberculosis testing market is segmented on the lines of its test type and regional. Based on test type segmentation the tuberculosis testing market covers drug susceptibility testing (DST), radiography (Chest X-Ray),  mantoux Test (Tuberculin Skin Test), nucleic acid testing, culture based tests, smear microscopy and other tests such as ADA, IGRA, serological tests etc. The tuberculosis testing market is geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

This report provides:

1) An overview of the global market for tuberculosis testing and related technologies.

2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2020.

3) Identifications of new market opportunities and targeted promotional plans for tuberculosis testing

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.


The scope of the report includes a detailed study of global and regional markets for tuberculosis testing with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, Akonni Biosystems, Inc., Alere, Inc., Becton, Dickinson and Company, bioMérieux SA, Cepheid, Epistem plc, F. Hoffmann-La Roche Ltd., Hain Lifescience GmbH, Hologic, QIAGEN, Sanofi and Thermo Fisher Scientific, Inc.. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

The Tuberculosis Testing Market has been segmented as below:  

By Test Type Analysis

•    Drug Susceptibility Testing (DST)
•    Radiography (Chest X-Ray)
•    Mantoux Test (Tuberculin Skin Test)
•    Nucleic Acid Testing
•    Culture Based Tests
•    Smear Microscopy
•    Other Tests (ADA, IGRA, Serological Tests etc)

By Regional Analysis

•    North America
•    Europe
•    Asia-Pacific
•    Rest of the World

For more information:

Editor's Details

John Bay
Market Research Engine

Last updated on: 29/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.